Virtus ETF Advisers LLC Erasca, Inc. Transaction History
Virtus ETF Advisers LLC
- $206 Million
- Q3 2024
A detailed history of Virtus ETF Advisers LLC transactions in Erasca, Inc. stock. As of the latest transaction made, Virtus ETF Advisers LLC holds 42,275 shares of ERAS stock, worth $111,183. This represents 0.06% of its overall portfolio holdings.
Number of Shares
42,275
Previous 41,526
1.8%
Holding current value
$111,183
Previous $98,000
17.35%
% of portfolio
0.06%
Previous 0.05%
Shares
10 transactions
Others Institutions Holding ERAS
# of Institutions
141Shares Held
229MCall Options Held
28.7KPut Options Held
117K-
Frazier Life Sciences Management, L.P. Menlo Park, CA19.4MShares$51 Million2.85% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD16.8MShares$44.3 Million0.03% of portfolio
-
Vr Adviser, LLC New York, NY16.2MShares$42.6 Million4.58% of portfolio
-
Suvretta Capital Management, LLC New York, NY13.8MShares$36.2 Million1.48% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.3MShares$34.9 Million0.0% of portfolio
About Erasca, Inc.
- Ticker ERAS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 122,147,000
- Market Cap $321M
- Description
- Erasca, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's lead candidates include ERAS-007, an oral inhibitor of ERK1/2 for the treatment of non-small cell lung cancer, colorectal cancer, and acute myeloid leukemia; ...